Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
21.00
+0.20 (0.96%)
At close: Feb 12, 2026
Market Cap51.58M -1.9%
Revenue (ttm)115.12M +7.4%
Net Income5.73M +17.7%
EPS2.33 +17.7%
Shares Out2.46M
PE Ratio8.99
Forward PEn/a
Dividend0.50 (2.40%)
Ex-Dividend DateSep 11, 2025
Volume110
Average Volume226
Open20.60
Previous Close20.80
Day's Range20.60 - 21.00
52-Week Range17.30 - 32.00
Beta0.20
RSI47.55
Earnings DateFeb 13, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 195
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.93 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 5.82 million, an increase of 14.22%.

Financial Statements